Industry expert sees combination drugs as new growth engine

Combination products will turn out to be tremendously lucrative as one of strategic items once they receive formal approval from a reliable drug-licensing agency and are put onto the market, according to a local market analyst.

“Combination drugs accounts for 28.5 percent of overall pharmaceutical market in Korea. We can expect huge profits from the combined preparations," said Kim Tae-hee, ...